Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +335.82%
#4 aPriori aPriori +148.53%
#5 Bedrock Bedrock +75.14%
#6 Cysic Cysic +50.00%
#7 Prom Prom +47.31%
#8 Playnance Playnance +34.96%
#9 Bitway Bitway +29.10%
#10 COTI COTI +25.76%
Coin of the day
Wrapped One Wrapped One
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Neurobiological Technologies, Inc. Neurobiological Technologies, Inc.

Neurobiological Technologies, Inc.

NTII
Rangering i aksjer #42270
Neurobiological Technologies, Inc. (NTII) is currently undergoing a liquidation... Neurobiological Technologies, Inc. (NTII) is currently undergoing a liquidation and dissolution process, a plan that received stockholder endorsement in October 2009. In its earlier operations, the company's core focus was on the development of experimental pharmaceutical treatments for various human ailments. This firm, which was established in 1987, has its primary location in Emeryville, California.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$2.70K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Neurobiological Technologies, Inc. (NTII)

Kategori

Healthcare
P/B-forhold for Neurobiological Technologies, Inc. (NTII)
P/B-forhold per 2026 TTM: 0
Ifølge Neurobiological Technologies, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Neurobiological Technologies, Inc. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR